FLUVASTATINE SANDOZ LP 80 mg, extended-release film-coated tablet 90 tablets
Active ingredients: Fluvastatin, (3R,5S)-fluvastatin sodium
Commercialized according to BDPMDispensing in France: Prescription only
Extended-release film-coated tablet90 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- FLUVASTATINE SANDOZ LP 80 mg, comprimé pelliculé à libération prolongée
- Pharmaceutical form
- comprimé pelliculé à libération prolongée
- Route of administration
- orale
- Presentation description
- plaquette(s) polyamide aluminium PVC-Aluminium de 90 comprimé(s)
- Marketing authorisation holder
- SANDOZ
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 15 Nov 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68067589CIP73879754CIP133400938797541Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| FLUVASTATINE SODIQUEcomprimé | — | SA |
| FLUVASTATINE BASEcomprimé | 80 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.